Piper Sandler Reiterates Overweight Rating on Glaukos Corporation (GKOS)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil gains after Trump says US will hit Iran 'very hard tonight'
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
- Wall Street indexes fall more than 1%, hit by tech, Iran war worries
Truist Securities Reiterates Buy Rating on Glaukos Corporation (GKOS)
October 21, 2024 8:34 AM EDTTruist Securities analyst Samuel Brodovsky reiterated a Buy rating and $152.00 price target on Glaukos Corporation (NYSE: GKOS).
The analyst comments "We summarize some feedback on iDose from the American Academy of Ophthalmology (AAO) conference & thoughts ahead of 3Q. A J-Code... More
